Tobacco Mosaic Viral Nanoparticle Inhibited Osteoclastogenesis Through Inhibiting mTOR/AKT Signaling
Related Experiment Video
Updated: Dec 5, 2025
Zhongshu Shan1,2, Hongtao Bi3, Angxiu Suonan2
1Department of Orthopedic Surgery, The 1st Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
Introduction:
Tobacco mosaic virus-based nanoparticles (TMV VNPs) were previously shown to promote osteogenic differentiation in vitro. This study aims to investigate whether and how TMV VNPs impact on osteoclastogenesis in vitro and bone injury healing in vivo.
Methods:
Raw264.7 cells were cultured in osteoclastogenic medium in culture plates coated with or without TMV and TMV-RGD1 VNPs, followed by TRAP staining, RT-qPCR and WB assessing expression of osteoclastogenic marker genes, and immunofluorescence assessing NF-κB activation. TMV and TMV-RGD1-modified hyaluronic acid hydrogel were used to treat mouse tibial bone injury. Bone injury healing was checked by micro-CT and Masson staining.
Results:
TMV and TMV-RGD1 VNPs significantly inhibited osteoclast differentiation and downregulated the expression of osteoclastogenic marker genes Ctr, Ctsk, Mmp-9, Rank, and Trap. Moreover, TMV and TMV-RGD1 VNPs inhibited NF-κB p65 phosphorylation and nuclear translocation, as well as activation of mTOR/AKT signaling pathway. TMV and TMV-RGD1-modified HA hydrogel strongly promoted mouse tibial bone injury with increased bone mass compared to plain HA hydrogel. The amount of osteoclasts was significantly reduced in TMV and TMV-RGD1 treated mice. TMV-RGD1 was more effective than TMV in inhibiting osteoclast differentiation and promoting bone injury repair.
Discussion:
These data demonstrated the great potential of TMV VNPs to be developed into biomaterial for bone injury repair or replacement.
Insights
Tobacco mosaic virus nanoparticles (TMV VNPs) inhibit osteoclast formation and enhance bone healing. TMV-RGD1 modified nanoparticles show superior efficacy in promoting bone repair and reducing osteoclasts.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Regenerative Medicine
Background:
- Tobacco mosaic virus-based nanoparticles (TMV VNPs) promote osteogenic differentiation.
- Investigating TMV VNPs' effects on osteoclastogenesis and bone healing is crucial.
Purpose of the Study:
- To evaluate the impact of TMV VNPs on osteoclastogenesis in vitro.
- To assess TMV VNPs' efficacy in promoting bone injury healing in vivo.
Main Methods:
- Osteoclast differentiation assays using Raw264.7 cells treated with TMV and TMV-RGD1 VNPs.
- In vivo study using TMV-RGD1-modified hyaluronic acid hydrogel for mouse tibial bone injury.
- Analysis included TRAP staining, gene expression, Western blotting, immunofluorescence, micro-CT, and Masson staining.
Main Results:
- TMV and TMV-RGD1 VNPs significantly inhibited osteoclast differentiation and downregulated key osteoclastogenic markers.
- TMV VNPs suppressed NF-κB and mTOR/AKT signaling pathways.
- TMV-RGD1 modified hydrogel significantly promoted bone healing and increased bone mass in vivo, with reduced osteoclast numbers.
Conclusions:
- TMV VNPs demonstrate significant potential as biomaterials for bone injury repair.
- TMV-RGD1 modification enhances the efficacy of TMV VNPs in bone regeneration.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Inhibition of Cdk Activity
MAPK Signaling Cascades


